# OnCo record laurence-albiges (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/laurence-albiges/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "laurence-albiges" ;
  schema:name "Laurence Albiges"@en ;
  schema:description "French kidney cancer specialist who co-led CheckMate 214 and the belzutifan trials."@en ;
  schema:url <https://onco.cc/people/laurence-albiges/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Albiges%20L%5BAuthor%5D%20renal%20cell> ;
  onco:tag "rcc", "hif2a", "guidelines" ;
  schema:jobTitle "Head of the Department of Medical Oncology, Gustave Roussy" ;
  onco:cancers <https://onco.cc/cancers/rcc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/hif2a/>, <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/belzutifan/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/> ;
  onco:institutions <https://onco.cc/institutions/gustave-roussy/> ;
  onco:trials <https://onco.cc/trials/checkmate-214/>, <https://onco.cc/trials/litespark-005/> ;
  onco:journals <https://onco.cc/journals/esmo-open/> ;
  schema:affiliation <https://onco.cc/institutions/gustave-roussy/> .